vs

Side-by-side financial comparison of FIRST FINANCIAL BANKSHARES INC (FFIN) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $164.7M, roughly 1.4× FIRST FINANCIAL BANKSHARES INC). FIRST FINANCIAL BANKSHARES INC runs the higher net margin — 44.5% vs 19.4%, a 25.1% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 12.0%). FIRST FINANCIAL BANKSHARES INC produced more free cash flow last quarter ($286.0M vs $34.8M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 12.7%).

First Financial Bank is a regional bank operated by First Financial Corporation and based in Terre Haute, Indiana. It is the oldest national bank in Indiana and the fifth oldest national bank in the United States. First Financial Corporation is Vigo County's only publicly traded company.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

FFIN vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.4× larger
ORGO
$225.6M
$164.7M
FFIN
Growing faster (revenue YoY)
ORGO
ORGO
+66.1% gap
ORGO
78.1%
12.0%
FFIN
Higher net margin
FFIN
FFIN
25.1% more per $
FFIN
44.5%
19.4%
ORGO
More free cash flow
FFIN
FFIN
$251.2M more FCF
FFIN
$286.0M
$34.8M
ORGO
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
12.7%
FFIN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FFIN
FFIN
ORGO
ORGO
Revenue
$164.7M
$225.6M
Net Profit
$73.3M
$43.7M
Gross Margin
Operating Margin
54.4%
28.1%
Net Margin
44.5%
19.4%
Revenue YoY
12.0%
78.1%
Net Profit YoY
17.6%
469.5%
EPS (diluted)
$0.51
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FFIN
FFIN
ORGO
ORGO
Q4 25
$164.7M
$225.6M
Q3 25
$161.3M
$150.9M
Q2 25
$156.6M
$101.0M
Q1 25
$149.0M
$86.7M
Q4 24
$147.1M
$126.7M
Q3 24
$139.5M
$115.2M
Q2 24
$134.5M
$130.2M
Q1 24
$129.6M
$110.0M
Net Profit
FFIN
FFIN
ORGO
ORGO
Q4 25
$73.3M
$43.7M
Q3 25
$52.3M
$21.6M
Q2 25
$66.7M
$-9.4M
Q1 25
$61.3M
$-18.8M
Q4 24
$62.3M
$7.7M
Q3 24
$55.3M
$12.3M
Q2 24
$52.5M
$-17.0M
Q1 24
$53.4M
$-2.1M
Gross Margin
FFIN
FFIN
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Q1 24
73.9%
Operating Margin
FFIN
FFIN
ORGO
ORGO
Q4 25
54.4%
28.1%
Q3 25
39.2%
13.7%
Q2 25
52.2%
-12.5%
Q1 25
50.4%
-30.9%
Q4 24
51.7%
8.1%
Q3 24
48.3%
5.4%
Q2 24
47.3%
-10.7%
Q1 24
50.0%
-3.5%
Net Margin
FFIN
FFIN
ORGO
ORGO
Q4 25
44.5%
19.4%
Q3 25
32.4%
14.3%
Q2 25
42.6%
-9.3%
Q1 25
41.2%
-21.7%
Q4 24
42.4%
6.1%
Q3 24
39.7%
10.7%
Q2 24
39.0%
-13.1%
Q1 24
41.2%
-1.9%
EPS (diluted)
FFIN
FFIN
ORGO
ORGO
Q4 25
$0.51
$0.31
Q3 25
$0.36
$0.11
Q2 25
$0.47
$-0.10
Q1 25
$0.43
$-0.17
Q4 24
$0.43
$0.05
Q3 24
$0.39
$0.09
Q2 24
$0.37
$-0.13
Q1 24
$0.37
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FFIN
FFIN
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$93.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.9B
$300.1M
Total Assets
$15.4B
$598.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FFIN
FFIN
ORGO
ORGO
Q4 25
$93.7M
Q3 25
$63.7M
Q2 25
$73.1M
Q1 25
$110.0M
Q4 24
$135.6M
Q3 24
$94.3M
Q2 24
$89.9M
Q1 24
$88.6M
Total Debt
FFIN
FFIN
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Q1 24
$65.2M
Stockholders' Equity
FFIN
FFIN
ORGO
ORGO
Q4 25
$1.9B
$300.1M
Q3 25
$1.8B
$255.1M
Q2 25
$1.7B
$233.2M
Q1 25
$1.7B
$242.9M
Q4 24
$1.6B
$262.9M
Q3 24
$1.7B
$278.5M
Q2 24
$1.5B
$263.5M
Q1 24
$1.5B
$278.0M
Total Assets
FFIN
FFIN
ORGO
ORGO
Q4 25
$15.4B
$598.7M
Q3 25
$14.8B
$509.8M
Q2 25
$14.4B
$461.1M
Q1 25
$14.3B
$467.4M
Q4 24
$14.0B
$497.9M
Q3 24
$13.6B
$446.3M
Q2 24
$13.2B
$443.2M
Q1 24
$13.2B
$458.5M
Debt / Equity
FFIN
FFIN
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FFIN
FFIN
ORGO
ORGO
Operating Cash FlowLast quarter
$299.4M
$39.4M
Free Cash FlowOCF − Capex
$286.0M
$34.8M
FCF MarginFCF / Revenue
173.6%
15.4%
Capex IntensityCapex / Revenue
8.2%
2.1%
Cash ConversionOCF / Net Profit
4.08×
0.90×
TTM Free Cash FlowTrailing 4 quarters
$503.1M
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FFIN
FFIN
ORGO
ORGO
Q4 25
$299.4M
$39.4M
Q3 25
$86.5M
$3.1M
Q2 25
$61.3M
$-32.9M
Q1 25
$76.8M
$-19.9M
Q4 24
$309.6M
$10.9M
Q3 24
$80.7M
$8.7M
Q2 24
$68.8M
$4.7M
Q1 24
$75.6M
$-10.2M
Free Cash Flow
FFIN
FFIN
ORGO
ORGO
Q4 25
$286.0M
$34.8M
Q3 25
$83.7M
$844.0K
Q2 25
$58.7M
$-36.5M
Q1 25
$74.7M
$-23.6M
Q4 24
$292.9M
$7.6M
Q3 24
$77.7M
$6.1M
Q2 24
$63.8M
$2.9M
Q1 24
$71.7M
$-12.4M
FCF Margin
FFIN
FFIN
ORGO
ORGO
Q4 25
173.6%
15.4%
Q3 25
51.9%
0.6%
Q2 25
37.5%
-36.1%
Q1 25
50.1%
-27.2%
Q4 24
199.1%
6.0%
Q3 24
55.7%
5.3%
Q2 24
47.4%
2.2%
Q1 24
55.3%
-11.3%
Capex Intensity
FFIN
FFIN
ORGO
ORGO
Q4 25
8.2%
2.1%
Q3 25
1.7%
1.5%
Q2 25
1.6%
3.6%
Q1 25
1.4%
4.2%
Q4 24
11.4%
2.7%
Q3 24
2.2%
2.2%
Q2 24
3.7%
1.4%
Q1 24
3.0%
2.0%
Cash Conversion
FFIN
FFIN
ORGO
ORGO
Q4 25
4.08×
0.90×
Q3 25
1.65×
0.14×
Q2 25
0.92×
Q1 25
1.25×
Q4 24
4.97×
1.43×
Q3 24
1.46×
0.71×
Q2 24
1.31×
Q1 24
1.42×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons